ACB $9.600 (-2.24%)

ACNNF $0.120 (1.69%)

AERO $3.210 (0%)

ALEAF $0.516 (-1.57%)

AMMJ $0.270 (38.46%)

APHA $15.710 (-5.98%)

ARNA $73.570 (2.88%)

ATT:CNX $0.080 (0%)

ATTBF $0.017 (0%)

AUSA:CNX $0.440 (1.15%)

AUSAF $0.346 (3.69%)

AVXL $11.870 (-7.48%)

BAMM:CNX $0.680 (4.62%)

BBM:CNX $0.185 (0%)

BBRRF $0.147 (-2.13%)

BE:CNX $0.005 (0%)

BIO:CNX $0.075 (-11.76%)

BLEVF $0.006 (0%)

BLIS:CNX $0.315 (0%)

BLO:CNX $1.380 (-6.76%)

BLOZF $1.100 (-6.78%)

BUDZ $0.780 (2.62%)

BXNG $0.480 (17.04%)

CADMF $0.541 (-8.6%)

CALI:CNX $0.100 (-9.09%)

CANN $0.910 (-4.21%)

CARA $18.090 (0.06%)

CBWTF $0.270 (2.93%)

CGC $31.170 (0.52%)

CGRW $0.169 (-6.06%)

CHOO:CNX $0.140 (0%)

CHOOF $0.111 (-2.51%)

CNBX $0.384 (9.69%)

CNGGF $0.497 (-2.55%)

CODI $23.820 (-0.71%)

CPMD $0.330 (0%)

CRBP $1.870 (-0.53%)

CRON $9.480 (-1.66%)

CROP:CNX $0.015 (0%)

CRTPF $3.160 (1.55%)

CRXPF $0.068 (0.15%)

CSI:CNX $0.690 (-8%)

CURR $0.890 (-9.18%)

CVSI $0.565 (-6.3%)

DIGP $0.058 (21.63%)

DXBRF $0.110 (-15.38%)

EAPH $0.002 (-13.64%)

EAT:CNX $0.025 (0%)

EEVVF $0.344 (-5%)

EMHTF $0.235 (11.05%)

EPWCF $0.588 (-1.52%)

EVIO $0.004 (19.35%)

FFRMF $0.055 (-0.36%)

FFT:CNX $0.040 (0%)

FNNZF $0.083 (-5.25%)

GGTTF $0.765 (12.1%)

GLDFF $0.043 (1.41%)

GLH:CNX $0.055 (0%)

GNBT $0.340 (13.33%)

GRIN:CNX $0.245 (-2%)

GRWG $40.400 (0.87%)

GTBIF $32.020 (-2.38%)

GTII:CNX $40.900 (-0.61%)

GWPH $214.940 (0.36%)

HEXO $6.420 (-1.53%)

HHPHF $0.013 (0%)

HLSPY $0.354 (10.63%)

HMLSF $9.197 (-2.83%)

HMPPF $0.498 (0%)

HRVOF $0.117 (1.3%)

HSTRF $0.255 (-3.51%)

HUGE:CNX $2.150 (-3.15%)

IAN:CNX $0.335 (3.08%)

IGC $1.630 (0%)

IGXT $0.290 (-9.09%)

IIPR $173.740 (-4.62%)

INQD $0.011 (10%)

IONC:CNX $0.235 (-2.08%)

IONKF $0.185 (-7.37%)

ISOL:CNX $0.035 (0%)

ISOLF $0.090 (19.87%)

ITHUF $0.260 (1.33%)

IVITF $0.040 (0%)

JWCAF $0.032 (220%)

KALTF $0.036 (-10%)

KBEV:CNX $0.140 (-3.45%)

KBEVF $0.111 (-5.43%)

KHRNF $0.330 (-7.59%)

KSHB $1.260 (-3.82%)

LHS:CNX $1.470 (0%)

LHSIF $1.145 (0%)

LOVE:CNX $0.160 (0%)

LXX:CNX $6.780 (-3.28%)

MCIG $0.028 (0%)

MEDIF $0.381 (2.06%)

MGWFF $0.064 (15.43%)

MJ:CNX $0.530 (-7.02%)

MJNA $0.060 (22.79%)

MNTR $0.179 (14.9%)

MRRCF $0.029 (2.3%)

MYM:CNX $0.135 (12.5%)

MYMMF $0.101 (7.02%)

NCNNF $0.203 (1.3%)

NDVAF $0.401 (-2.91%)

NGW:CNX $0.890 (5.95%)

NRXCF $0.109 (0%)

NSPDF $0.051 (-1.54%)

NTEC $3.970 (6.72%)

NVTQF $0.112 (0%)

NWKRF $0.424 (0%)

NXGWF $0.719 (5.83%)

NXTTF $0.241 (1.86%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.012 (13.86%)

PHCG $0.490 (0%)

PHVAF $0.038 (0%)

PILL:CNX $0.950 (1.06%)

PKG:CNX $0.160 (-3.03%)

PLPRF $0.630 (-4.27%)

PLUS:CNX $0.820 (1.23%)

PMCB $0.022 (14.51%)

PNPL $0.690 (0%)

POTN $0.011 (2.73%)

PRCNF $0.020 (-12.28%)

PTNYF $0.127 (4.26%)

QCA:CNX $0.185 (2.78%)

RDDTF $0.088 (3.29%)

RLLVF $0.023 (-11.74%)

RMHB $0.050 (-7.41%)

RQB:CNX $0.005 (0%)

RQHTF $0.506 (-5.03%)

RVVQF $0.020 (63.75%)

SLNG:CNX $0.440 (-6.38%)

SMG $200.980 (1.4%)

SNN:CNX $0.155 (0%)

SNNVF $0.110 (0%)

SOL:CNX $3.040 (-7.88%)

SOLCF $2.339 (-9.71%)

SPLIF $0.017 (0%)

SPRWF $0.197 (-2.29%)

SRNA $0.090 (5.88%)

STEM:CNX $0.960 (4.35%)

STMH $0.750 (6.38%)

SUN:CNX $0.150 (0%)

TBPMF $0.126 (2.76%)

TCAN:CNX $1.330 (0.76%)

TCNAF $1.010 (-3.81%)

TER:CNX $15.490 (-6.4%)

TGEN $2.110 (-8.26%)

TGIF:CNX $0.110 (0%)

TGIFF $0.085 (2.04%)

THC:CNX $0.170 (0%)

THCBF $0.134 (0.15%)

TLRY $21.630 (-4.5%)

TOKI:CNX $0.025 (0%)

TRLFF $0.411 (-13.42%)

TRSSF $12.255 (-6.45%)

TRTC $0.376 (5.97%)

TURV $0.052 (4.51%)

VBIO $0.220 (69.23%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.140 (7.69%)

VPRB $0.065 (0%)

VRNDF $0.414 (0.9%)

VRT:CNX $0.150 (0%)

VRTHF $0.115 (0%)

VVCIF $0.130 (-3.7%)

WAYL:CNX $0.740 (0%)

WDDMF $0.337 (2.12%)

WLDFF $0.140 (16.63%)

XXII $2.400 (10.09%)

ZDPY $0.653 (-0.38%)

ZYNE $4.150 (1.47%)

Technical420 Site Search

Returned 93 result(s).

MediPharm Labs Closes Previously Announced Bought Deal Equity Financing

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the closing of its previously announced “bought deal” offering of units of the Company (the “Units”) for total gross proceeds…

MediPharm Labs Announces $20 million Bought Deal Equity Financing

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that it has entered into an agreement with Cantor Fitzgerald Canada Corp., as lead underwriter and sole bookrunner on behalf…

Medipharm Labs Has Taken Another Major Step Forward To Advance The Company’s Entry Into The Pharmaceutical Sector

Last year, we highlighted MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) as one of the most misunderstood and undervalued cannabis companies. Following a series of transformational announcements, we remain bullish on the business and believe that our readers need to be aware of how the story has advanced…

MediPharm Labs Receives Milestone Cannabis Drug Licence to Manufacture and Distribute Pharmaceuticals Containing Cannabis Including New Drugs for Discovery Trials

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, announced it has received a Cannabis Drug Licence (“CDL licence”) from Health Canada. The CDL licence is a critical licence required in the qualification…

Cannabis Biotech Firms Are Getting A Huge Boost In Interest After The Multi-Billion Dollar Acquisition Of GW Pharmaceuticals

2021 has been a banner year for the cannabis sector and we have not even completed two months of the year. So far this year, one of the most significant developments for the cannabis sector was Jazz Pharmaceuticals’ (JAZZ: Nasdaq) acquisition of GW Pharmaceuticals (GWPH: Nasdaq) for more than $7…

MediPharm Labs Appoints New Chief Financial Officer

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce Greg Hunter will join MediPharm Labs as Chief Financial Officer (CFO), effective February 8, 2021. Greg Hunter brings over 20 years of experience as a…

MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of Directors

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the appointment of Warren Everitt to its Board of Directors (the “Board”), effective immediately. Mr. Everitt joined MediPharm Labs in 2017 to establish the Company’s presence in…

Medipharm Labs Domestic Cannabis Business Is A Boomin’

Earlier this week, MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced a major milestone and reported a record number of finished goods shipments in the fourth quarter. During the quarter, MediPharm reported to have shipped 550,000 units to Canadians and we are impressed with how the business has…

MediPharm Labs Ships Company Record 550,000 Units in Q4 2020

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, achieved Company record finished goods shipments of 550,000 units in the fourth quarter of 2020. These results and the update that follows reflect corporate…

The Canadian Cannabis Extracts Market Is One Investors Should Be Watching In 2021

To follow up on the first publication from a planned series of articles that are focused the global cannabis opportunity in 2021, we want to highlight the Canadian cannabis concentrate market. In our opinion, this is an under-appreciated vertical of the Canadian cannabis market that has substantial growth prospects. Following…

Older Posts »

Search Again